The Th17 lineage: Answers to some immunological questions

Mosmann, 1986, Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, J Immunol, 136, 2348, 10.4049/jimmunol.136.7.2348 Harrington, 2005, Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nat Immunol, 6, 1123, 10.1038/ni1254 Park, 2005, A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nat Immunol, 6, 1133, 10.1038/ni1261 Rouvier, 1993, CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene, J Immunol, 150, 5445, 10.4049/jimmunol.150.12.5445 Yao, 1995, Human IL-17: A novel cytokine derived from T cells, J Immunol, 155, 5483, 10.4049/jimmunol.155.12.5483 Chang, 2007, A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses, Cell Res, 17, 435, 10.1038/cr.2007.35 Wright, 2007, Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells, J Biol Chem, 282, 13447, 10.1074/jbc.M700499200 Liang, 2007, An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment, J Immunol, 179, 7791, 10.4049/jimmunol.179.11.7791 Moseley, 2003, Interleukin-17 family and IL-17 receptors, Cytokine Growth Factor Rev, 14, 155, 10.1016/S1359-6101(03)00002-9 Haudenschild, 2002, Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer, J Biol Chem, 277, 4309, 10.1074/jbc.M109372200 Hymowitz, 2001, IL-17s adopt a cystine knot fold: Structure and activity of a novel cytokine IL-17F, and implications for receptor binding, EMBO J, 20, 5332, 10.1093/emboj/20.19.5332 Gaffen, 2008, An overview of IL-17 function and signaling, Cytokine, 43, 402, 10.1016/j.cyto.2008.07.017 Shalom-Barak, 1998, Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB, J Biol Chem, 273, 27467, 10.1074/jbc.273.42.27467 Hata, 2002, IL-17 stimulates inflammatory responses via NF-κB and MAP kinase pathways in human colonic myofibroblasts, Am J Physiol Gastrointest Liver Physiol, 282, G1035, 10.1152/ajpgi.00494.2001 Shen, 2006, Identification of common transcriptional regulatory elements in interleukin-17 target genes, J Biol Chem, 281, 24138, 10.1074/jbc.M604597200 Patel, 2007, Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-κB and C/EBP‚ activation, J Biol Chem, 282, 27229, 10.1074/jbc.M703250200 Schwandner, 2000, Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction, J Exp Med, 191, 1233, 10.1084/jem.191.7.1233 Hartupee, 2007, IL-17 enhances chemokine gene expression through mRNA stabilization, J Immunol, 179, 4135, 10.4049/jimmunol.179.6.4135 Infante-Duarte, 2000, Microbial lipopeptides induce the production of IL-17 in Th cells, J Immunol, 165, 6107, 10.4049/jimmunol.165.11.6107 Bettelli, 2004, Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis, J Exp Med, 200, 79, 10.1084/jem.20031819 Zhang, 2003, Induction of experimental autoimmune encephalomyelitis in IL-12 receptorbeta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system, J Immunol, 170, 2153, 10.4049/jimmunol.170.4.2153 Billiau, 1988, Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ, J Immunol, 140, 1506, 10.4049/jimmunol.140.5.1506 Gran, 2004, Early administration of IL-12 suppresses EAE through induction of interferon-γ, J Neuroimmunol, 156, 123, 10.1016/j.jneuroim.2004.07.019 Gran, 2002, IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination, J Immunol, 169, 7104, 10.4049/jimmunol.169.12.7104 Voorthuis, 1990, Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-γ in Lewis rats, Clin Exp Immunol, 81, 183, 10.1111/j.1365-2249.1990.tb03315.x Willenborg, 1999, IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide, J Immunol, 163, 5278, 10.4049/jimmunol.163.10.5278 Oppmann, 2000, Novel p19 protein engages IL-12p40 to form a cytokine IL-23, with biological activities similar as well as distinct from IL-12, Immunity, 13, 715, 10.1016/S1074-7613(00)00070-4 Cua, 2003, Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, Nature, 421, 744, 10.1038/nature01355 Langrish, 2005, IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, J Exp Med, 201, 233, 10.1084/jem.20041257 Chen, 2006, Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis, J Clin Invest, 116, 1317, 10.1172/JCI25308 Murphy, 2003, Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation, J Exp Med, 198, 1951, 10.1084/jem.20030896 Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753 Mangan, 2006, Transforming growth factor-β induces development of the T(H)17 lineage, Nature, 441, 231, 10.1038/nature04754 Veldhoen, 2006, Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease, Nat Immunol, 7, 1151, 10.1038/ni1391 Lohr, 2006, Regulatory T cells in the periphery, Immunol Rev, 212, 149, 10.1111/j.0105-2896.2006.00414.x Acosta-Rodriguez, 2007, Interleukins 1‚ and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells, Nat Immunol, 8, 942, 10.1038/ni1496 Chen, 2007, Distinct regulation of interleukin-17 in human T helper lymphocytes, Arthritis Rheum, 56, 2936, 10.1002/art.22866 van Beelen, 2007, Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells, Immunity, 27, 660, 10.1016/j.immuni.2007.08.013 Wilson, 2007, Development, cytokine profile and function of human interleukin 17-producing helper T cells, Nat Immunol, 8, 950, 10.1038/ni1497 Yang, 2008, IL-21 and TGF-β are required for differentiation of human T(H)17 cells, Nature, 454, 350, 10.1038/nature07021 Manel, 2008, The differentiation of human T(H)-17 cells requires transforming growth factor-‚ and induction of the nuclear receptor RORγt, Nat Immunol, 9, 641, 10.1038/ni.1610 Volpe, 2008, A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses, Nat Immunol, 9, 650, 10.1038/ni.1613 O’Garra, 2008, Differentiation of human T(H)-17 cells does require TGF-β!, Nat Immunol, 9, 588, 10.1038/ni0608-588 Aggarwal, 2003, Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17, J Biol Chem, 278, 1910, 10.1074/jbc.M207577200 Veldhoen, 2006, TGF‚ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, Immunity, 24, 179, 10.1016/j.immuni.2006.01.001 Stritesky, 2008, IL-23 promotes maintenance but not commitment to the Th17 lineage, J Immunol, 181, 5948, 10.4049/jimmunol.181.9.5948 McGeachy, 2007, TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology, Nat Immunol, 8, 1390, 10.1038/ni1539 Zhou, 2007, IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways, Nat Immunol, 8, 967, 10.1038/ni1488 Ogura, 2008, Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction, Immunity, 29, 628, 10.1016/j.immuni.2008.07.018 Kimura, 2007, IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells, Proc Natl Acad Sci USA, 104, 12099, 10.1073/pnas.0705268104 Nurieva, 2007, Essential autocrine regulation by IL-21 in the generation of inflammatory T cells, Nature, 448, 480, 10.1038/nature05969 Korn, 2007, IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells, Nature, 448, 484, 10.1038/nature05970 Wei, 2007, IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner, J Biol Chem, 282, 34605, 10.1074/jbc.M705100200 Sutton, 2006, A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis, J Exp Med, 203, 1685, 10.1084/jem.20060285 Gutcher, 2006, Interleukin 18-independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation, Nat Immunol, 7, 946, 10.1038/ni1377 Murphy, 2002, The lineage decisions of helper T cells, Nat Rev Immunol, 2, 933, 10.1038/nri954 Stumhofer, 2007, Negative regulation of Th17 responses, Semin Immunol, 19, 394, 10.1016/j.smim.2007.11.006 Colgan, 2006, All in the family: IL-27 suppression of T(H)-17 cells, Nat Immunol, 7, 899, 10.1038/ni0906-899 Batten, 2006, Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells, Nat Immunol, 7, 929, 10.1038/ni1375 Stumhofer, 2006, Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system, Nat Immunol, 7, 937, 10.1038/ni1376 Stumhofer, 2007, Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10, Nat Immunol, 8, 1363, 10.1038/ni1537 Jankovic, 2007, IL-10 or not IL-10: That is the question, Nat Immunol, 8, 1281, 10.1038/ni1207-1281 Fort, 2001, IL-25 induces IL-4 IL-5, and IL-13 and Th2-associated pathologies in vivo, Immunity, 15, 985, 10.1016/S1074-7613(01)00243-6 Owyang, 2006, Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract, J Exp Med, 203, 843, 10.1084/jem.20051496 Kleinschek, 2007, IL-25 regulates Th17 function in autoimmune inflammation, J Exp Med, 204, 161, 10.1084/jem.20061738 Abbas, 2003, The control of T cell activation vs. tolerance, Autoimmun Rev, 2, 115, 10.1016/S1568-9972(03)00028-4 Shevach, 2006, The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells, Immunol Rev, 212, 60, 10.1111/j.0105-2896.2006.00415.x Laurence, 2007, Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation, Immunity, 26, 371, 10.1016/j.immuni.2007.02.009 Matsuzaki, 2007, Interleukin-17 as an effector molecule of innate and acquired immunity against infections, Microbiol Immunol, 51, 1139, 10.1111/j.1348-0421.2007.tb04008.x Linden, 2005, Neutrophils, interleukin-17A and lung disease, Eur Respir J, 25, 159, 10.1183/09031936.04.00032904 Ivanov, 2006, The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, 126, 1121, 10.1016/j.cell.2006.07.035 Aujla, 2008, IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia, Nat Med, 14, 275, 10.1038/nm1710 Ye, 2001, Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense, J Exp Med, 194, 519, 10.1084/jem.194.4.519 Yang, 2008, Regulation of inflammatory responses by IL-17F, J Exp Med, 205, 1063, 10.1084/jem.20071978 Chung, 2003, CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism, J Immunol, 170, 1958, 10.4049/jimmunol.170.4.1958 Huang, 2004, Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice, J Infect Dis, 190, 624, 10.1086/422329 Zelante, 2007, IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance, Eur J Immunol, 37, 2695, 10.1002/eji.200737409 Kleinschek, 2006, IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12, J Immunol, 176, 1098, 10.4049/jimmunol.176.2.1098 Rudner, 2007, Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection, Infect Immun, 75, 3055, 10.1128/IAI.01329-06 Kelly, 2005, Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection, Infect Immun, 73, 617, 10.1128/IAI.73.1.617-621.2005 Yao, 1995, Herpesvirus Saimiri encodes a new cytokine IL-17, which binds to a novel cytokine receptor, Immunity, 3, 811, 10.1016/1074-7613(95)90070-5 Maertzdorf, 2002, IL-17 expression in human herpetic stromal keratitis: Modulatory effects on chemokine production by corneal fibroblasts, J Immunol, 169, 5897, 10.4049/jimmunol.169.10.5897 Patera, 2002, Interleukin 17 modulates the immune response to vaccinia virus infection, Virology, 299, 56, 10.1006/viro.2002.1400 Smiley, 2007, Association of γ interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G), J Virol, 81, 3740, 10.1128/JVI.01877-06 Komiyama, 2006, IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis, J Immunol, 177, 566, 10.4049/jimmunol.177.1.566 Nakae, 2003, Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice, J Immunol, 171, 6173, 10.4049/jimmunol.171.11.6173 Lubberts, 2004, Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collageninduced arthritis reduces joint inflammation, cartilage destruction, and bone erosion, Arthritis Rheum, 50, 650, 10.1002/art.20001 Rohn, 2006, Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis, Eur J Immunol, 36, 2857, 10.1002/eji.200636658 Uyttenhove, 2006, Development of an anti-IL-17A autovaccine that prevents experimental auto-immune encephalomyelitis, Eur J Immunol, 36, 2868, 10.1002/eji.200636662 Weinstock-Guttman, 2008, Interferon-β treatment for relapsing multiple sclerosis, Expert Opin Biol Ther, 8, 1435, 10.1517/14712598.8.9.1435 Martin-Saavedra, 2007, Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitis, Mol Immunol, 44, 3597, 10.1016/j.molimm.2007.03.002 Martin-Saavedra, 2008, Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells, Mol Immunol, 45, 4008, 10.1016/j.molimm.2008.06.006 Guo, 2008, The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice, J Clin Invest, 118, 1680, 10.1172/JCI33342 Rojo, 2008, CD4+ICOS+ T lymphocytes inhibit T cell activation ‘in vitro’ and attenuate autoimmune encephalitis ‘in vivo’, Int Immunol, 20, 577, 10.1093/intimm/dxn016 Kotake, 1999, IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis, J Clin Invest, 103, 1345, 10.1172/JCI5703 Kim, 2007, Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-NF-κB- and p38 MAPK-dependent signalling pathways, Rheumatology (Oxford), 46, 57, 10.1093/rheumatology/kel159 Cho, 2004, Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: Cross-talk between T cells and synovial fibroblasts, Arthritis Rheum, 50, 776, 10.1002/art.20106 Hwang, 2004, IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways, Arthritis Res Ther, 6, R120, 10.1186/ar1038 Matusevicius, 1999, Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis, Mult Scler, 5, 101, 10.1177/135245859900500206 Lock, 2002, Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis, Nat Med, 8, 500, 10.1038/nm0502-500 Acosta-Rodriguez, 2007, Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells, Nat Immunol, 8, 639, 10.1038/ni1467 Sato, 2007, Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5– phenotype, J Immunol, 178, 7525, 10.4049/jimmunol.178.12.7525 Vaknin-Dembinsky, 2006, IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production, J Immunol, 176, 7768, 10.4049/jimmunol.176.12.7768 Kebir, 2007, Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation, Nat Med, 13, 1173, 10.1038/nm1651 Tzartos, 2008, Interleukin-17 production in central nervous systeminfiltrating T cells and glial cells is associated with active disease in multiple sclerosis, Am J Pathol, 172, 146, 10.2353/ajpath.2008.070690 Teunissen, 1998, Interleukin-17 and interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes, J Invest Dermatol, 111, 645, 10.1046/j.1523-1747.1998.00347.x Liang, 2006, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides, J Exp Med, 203, 2271, 10.1084/jem.20061308 Wong, 2008, Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity, Clin Immunol, 127, 385, 10.1016/j.clim.2008.01.019 Uhlig, 2006, Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology, Immunity, 25, 309, 10.1016/j.immuni.2006.05.017 Yen, 2006, IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6, J Clin Invest, 116, 1310, 10.1172/JCI21404 Zhang, 2006, Critical role of IL-17 receptor signaling in acute TNBS-induced colitis, Inflamm Bowel Dis, 12, 382, 10.1097/01.MIB.0000218764.06959.91 Fujino, 2003, Increased expression of interleukin 17 in inflammatory bowel disease, Gut, 52, 65, 10.1136/gut.52.1.65 Annunziato, 2007, Phenotypic and functional features of human Th17 cells, J Exp Med, 204, 1849, 10.1084/jem.20070663 Ouyang, 2008, The biological functions of T helper 17 cell effector cytokines in inflammation, Immunity, 28, 454, 10.1016/j.immuni.2008.03.004 Fahy, 1995, Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation, J Allergy Clin Immunol, 95, 843, 10.1016/S0091-6749(95)70128-1 Wenzel, 1999, Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics, Am J Respir Crit Care Med, 160, 1001, 10.1164/ajrccm.160.3.9812110 Jatakanon, 1999, Neutrophilic inflammation in severe persistent asthma, Am J Respir Crit Care Med, 160, 1532, 10.1164/ajrccm.160.5.9806170 Ordonez, 2000, Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance, Am J Respir Crit Care Med, 161, 1185, 10.1164/ajrccm.161.4.9812061 Gibson, 2001, Heterogeneity of airway inflammation in persistent asthma: Evidence of neutrophilic inflammation and increased sputum interleukin-8, Chest, 119, 1329, 10.1378/chest.119.5.1329 Hellings, 2003, Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma, Am J Respir Cell Mol Biol, 28, 42, 10.1165/rcmb.4832 Prause, 2004, Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways, Thorax, 59, 313, 10.1136/thx.2003.008854 Hoshino, 2000, Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo, J Allergy Clin Immunol, 105, 143, 10.1016/S0091-6749(00)90189-1 Oboki, 2008, Th17 and allergy, Allergol Int, 57, 121, 10.2332/allergolint.R-07-160 Lee, 2006, T helper cell differentiation: Regulation by cis elements and epigenetics, Immunity, 24, 369, 10.1016/j.immuni.2006.03.007 Yang, 2008, T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR α and ROR γ, Immunity, 28, 29, 10.1016/j.immuni.2007.11.016 Eberl, 2003, The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches, Immunol Rev, 195, 81, 10.1034/j.1600-065X.2003.00074.x Yang, 2007, STAT3 regulates cytokine-mediated generation of inflammatory helper T cells, J Biol Chem, 282, 9358, 10.1074/jbc.C600321200 Harris, 2007, Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity, J Immunol, 179, 4313, 10.4049/jimmunol.179.7.4313 Chen, 2007, Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation, Semin Immunol, 19, 400, 10.1016/j.smim.2007.10.015 Chen, 2006, Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells, Proc Natl Acad Sci USA, 103, 8137, 10.1073/pnas.0600666103 Hu, 2002, Modulation of T cell cytokine production by interferon regulatory factor-4, J Biol Chem, 277, 49238, 10.1074/jbc.M205895200 Lohoff, 2002, Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4, Proc Natl Acad Sci USA, 99, 11808, 10.1073/pnas.182425099 Rengarajan, 2002, Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression, J Exp Med, 195, 1003, 10.1084/jem.20011128 Brustle, 2007, The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4, Nat Immunol, 8, 958, 10.1038/ni1500 Ichiyama, 2008, Foxp3 inhibits RORγt-mediated IL-17A mRNA transcription through direct interaction with RORγt, J Biol Chem, 283, 17003, 10.1074/jbc.M801286200 Zhang, 2008, Interactions among the transcription factors Runx1 RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells, Nat Immunol, 9, 1297, 10.1038/ni.1663 Liu, 2004, Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17, J Biol Chem, 279, 52762, 10.1074/jbc.M405764200 Akimzhanov, 2007, Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation, J Biol Chem, 282, 5969, 10.1074/jbc.C600322200 Sakaguchi, 2000, cells: Key controllers of immunologic self-tolerance, Cell, 101, 455, 10.1016/S0092-8674(00)80856-9 Chen, 2003, Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3, J Exp Med, 198, 1875, 10.1084/jem.20030152 Faria, 2006, Oral tolerance and TGF-β-producing cells, Inflamm Allergy Drug Targets, 5, 179, 10.2174/187152806778256034 Pini, 2007, The renaissance of T regulatory cells: Looking for markers in a haystack, Inmunología, 26, 100, 10.1016/S0213-9626(07)70080-X Zhou, 2008, TGF-β-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORγt function, Nature, 453, 236, 10.1038/nature06878 Schambach, 2007, Activation of retinoic acid receptor-α favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation, Eur J Immunol, 37, 2396, 10.1002/eji.200737621 Elias, 2008, Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway, Blood, 111, 1013, 10.1182/blood-2007-06-096438 Mucida, 2007, Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid, Science, 317, 256, 10.1126/science.1145697 Molina, 1993, Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressor, Cell, 75, 875, 10.1016/0092-8674(93)90532-U Lalli, 1993, Nuclear response to cyclic AMP: Central role of transcription factor CREM (cyclic-AMP-responsive-element modulator), Biochem Soc Trans, 21, 912, 10.1042/bst0210912 Bopp, 2007, Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression, J Exp Med, 204, 1303, 10.1084/jem.20062129 Chizzolini, 2008, Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion, Blood, 112, 3696, 10.1182/blood-2008-05-155408 Yadav, 2008, Cutting edge: Vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile, J Immunol, 180, 2772, 10.4049/jimmunol.180.5.2772 Yang, 2008, Molecular antagonism and plasticity of regulatory and inflammatory T cell programs, Immunity, 29, 44, 10.1016/j.immuni.2008.05.007